Reiley Pharmaceuticals

About:

Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases.

Description:

Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases. The company's biopharmaceutical products enable patients to recover from pain, cancer, and infectious diseases. The company was founded in 2014 and is based in San Francisco, California, United States.

Total Funding Amount:

$3.28M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2014-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2017-11-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai